Annual D&A
$5.65 M
-$970.00 K-14.65%
December 31, 2024
Summary
- As of March 12, 2025, AGIO annual depreciation & amortization is $5.65 million, with the most recent change of -$970.00 thousand (-14.65%) on December 31, 2024.
- During the last 3 years, AGIO annual D&A has fallen by -$3.59 million (-38.82%).
- AGIO annual D&A is now -42.26% below its all-time high of $9.79 million, reached on December 31, 2020.
Performance
AGIO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.37 M
+$22.00 K+1.64%
December 31, 2024
Summary
- As of March 12, 2025, AGIO quarterly depreciation & amortization is $1.37 million, with the most recent change of +$22.00 thousand (+1.64%) on December 31, 2024.
- Over the past year, AGIO quarterly D&A has dropped by -$36.00 thousand (-2.57%).
- AGIO quarterly D&A is now -47.18% below its all-time high of $2.59 million, reached on December 31, 2020.
Performance
AGIO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$5.65 M
-$36.00 K-0.63%
December 31, 2024
Summary
- As of March 12, 2025, AGIO TTM depreciation & amortization is $5.65 million, with the most recent change of -$36.00 thousand (-0.63%) on December 31, 2024.
- Over the past year, AGIO TTM D&A has dropped by -$970.00 thousand (-14.65%).
- AGIO TTM D&A is now -42.29% below its all-time high of $9.79 million, reached on March 31, 2021.
Performance
AGIO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
AGIO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.7% | -2.6% | -14.7% |
| 3 y3 years | -38.8% | -2.6% | -14.7% |
| 5 y5 years | -30.1% | -2.6% | -14.7% |
AGIO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.8% | at low | -44.8% | +1.6% | -38.8% | at low |
| 5 y | 5-year | -42.3% | at low | -47.2% | +1.6% | -42.3% | at low |
| alltime | all time | -42.3% | +605.7% | -47.2% | +417.8% | -42.3% | +2041.3% |
Agios Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $5.65 M(-14.6%) | $1.37 M(+1.6%) | $5.65 M(-0.6%) |
| Sep 2024 | - | $1.34 M(-15.6%) | $5.69 M(-4.7%) |
| Jun 2024 | - | $1.59 M(+18.2%) | $5.97 M(-3.5%) |
| Mar 2024 | - | $1.35 M(-3.9%) | $6.18 M(-6.7%) |
| Dec 2023 | $6.62 M(-22.7%) | $1.40 M(-13.6%) | $6.62 M(-5.8%) |
| Sep 2023 | - | $1.62 M(-10.2%) | $7.03 M(-4.8%) |
| Jun 2023 | - | $1.81 M(+0.9%) | $7.39 M(-6.1%) |
| Mar 2023 | - | $1.79 M(-1.3%) | $7.88 M(-8.0%) |
| Dec 2022 | $8.56 M(-7.3%) | $1.81 M(-8.4%) | $8.56 M(-4.3%) |
| Sep 2022 | - | $1.98 M(-13.5%) | $8.95 M(-2.5%) |
| Jun 2022 | - | $2.29 M(-7.5%) | $9.18 M(-0.6%) |
| Mar 2022 | - | $2.48 M(+12.5%) | $9.24 M(-0.0%) |
| Dec 2021 | $9.24 M(-5.6%) | $2.20 M(-0.3%) | $9.24 M(-4.0%) |
| Sep 2021 | - | $2.21 M(-6.0%) | $9.63 M(-1.1%) |
| Jun 2021 | - | $2.35 M(-5.2%) | $9.73 M(-0.6%) |
| Mar 2021 | - | $2.48 M(-4.2%) | $9.79 M(+0.1%) |
| Dec 2020 | $9.79 M(+21.0%) | $2.59 M(+11.8%) | $9.79 M(+6.8%) |
| Sep 2020 | - | $2.31 M(-4.1%) | $9.17 M(+2.6%) |
| Jun 2020 | - | $2.41 M(-2.5%) | $8.93 M(+4.4%) |
| Mar 2020 | - | $2.47 M(+26.0%) | $8.56 M(+5.8%) |
| Dec 2019 | $8.09 M(+12.8%) | $1.96 M(-5.7%) | $8.09 M(+0.7%) |
| Sep 2019 | - | $2.08 M(+2.2%) | $8.04 M(+3.7%) |
| Jun 2019 | - | $2.04 M(+1.6%) | $7.75 M(+4.0%) |
| Mar 2019 | - | $2.00 M(+4.9%) | $7.45 M(+3.9%) |
| Dec 2018 | $7.17 M | $1.91 M(+6.3%) | $7.17 M(+3.7%) |
| Sep 2018 | - | $1.80 M(+3.3%) | $6.92 M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $1.74 M(+0.8%) | $6.73 M(+2.5%) |
| Mar 2018 | - | $1.73 M(+4.3%) | $6.57 M(+2.1%) |
| Dec 2017 | $6.43 M(+12.7%) | $1.65 M(+2.5%) | $6.43 M(-1.0%) |
| Sep 2017 | - | $1.61 M(+2.6%) | $6.50 M(+2.8%) |
| Jun 2017 | - | $1.57 M(-1.1%) | $6.32 M(+4.4%) |
| Mar 2017 | - | $1.59 M(-7.6%) | $6.05 M(+6.0%) |
| Dec 2016 | $5.71 M(+70.8%) | $1.72 M(+19.9%) | $5.71 M(+11.2%) |
| Sep 2016 | - | $1.44 M(+10.1%) | $5.13 M(+8.2%) |
| Jun 2016 | - | $1.30 M(+4.7%) | $4.74 M(+12.4%) |
| Mar 2016 | - | $1.25 M(+8.8%) | $4.22 M(+26.2%) |
| Dec 2015 | $3.34 M(+144.5%) | $1.15 M(+9.4%) | $3.34 M(+30.6%) |
| Sep 2015 | - | $1.05 M(+34.2%) | $2.56 M(+37.7%) |
| Jun 2015 | - | $780.00 K(+110.8%) | $1.86 M(+32.2%) |
| Mar 2015 | - | $370.00 K(+2.2%) | $1.41 M(+2.8%) |
| Dec 2014 | $1.37 M(-5.1%) | $362.00 K(+4.6%) | $1.37 M(+1.6%) |
| Sep 2014 | - | $346.00 K(+5.8%) | $1.34 M(-2.3%) |
| Jun 2014 | - | $327.00 K(-1.5%) | $1.38 M(-3.3%) |
| Mar 2014 | - | $332.00 K(-2.4%) | $1.42 M(-1.2%) |
| Dec 2013 | $1.44 M(+22.1%) | $340.00 K(-9.8%) | $1.44 M(+1.2%) |
| Sep 2013 | - | $377.00 K(+0.8%) | $1.42 M(+4.2%) |
| Jun 2013 | - | $374.00 K(+7.2%) | $1.36 M(+8.0%) |
| Mar 2013 | - | $349.00 K(+8.0%) | $1.26 M(+7.2%) |
| Dec 2012 | $1.18 M(+47.2%) | $323.00 K(+1.3%) | $1.18 M(+37.7%) |
| Sep 2012 | - | $319.00 K(+16.8%) | $856.00 K(+59.4%) |
| Jun 2012 | - | $273.00 K(+3.4%) | $537.00 K(+103.4%) |
| Mar 2012 | - | $264.00 K | $264.00 K |
| Dec 2011 | $801.00 K | - | - |
FAQ
- What is Agios Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual D&A year-on-year change?
- What is Agios Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly D&A year-on-year change?
- What is Agios Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM D&A year-on-year change?
What is Agios Pharmaceuticals annual depreciation & amortization?
The current annual D&A of AGIO is $5.65 M
What is the all time high annual D&A for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual depreciation & amortization is $9.79 M
What is Agios Pharmaceuticals annual D&A year-on-year change?
Over the past year, AGIO annual depreciation & amortization has changed by -$970.00 K (-14.65%)
What is Agios Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of AGIO is $1.37 M
What is the all time high quarterly D&A for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly depreciation & amortization is $2.59 M
What is Agios Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, AGIO quarterly depreciation & amortization has changed by -$36.00 K (-2.57%)
What is Agios Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of AGIO is $5.65 M
What is the all time high TTM D&A for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM depreciation & amortization is $9.79 M
What is Agios Pharmaceuticals TTM D&A year-on-year change?
Over the past year, AGIO TTM depreciation & amortization has changed by -$970.00 K (-14.65%)